ĐIệN TOáN ĐáM MÂY Và BàI TOáN Xử Lí Dữ LIệU LớN THEO MÔ HìNH ÁNH Xạ - RúT GọN


Intrathecal administration of a novel siRNA modality extends survival and improves motor function in the SOD1G93A ALS mouse model

Antisense oligonucleotides (ASOs) were the first modality to pioneer targeted gene knockdown in the treatment of amyotrophic lateral sclerosis (ALS) caused by mutant superoxide dismutase 1 (SOD1).RNA interference (RNAi) is another mechanism of gene silencing in which short interfering RNAs (siRNAs) effectively degrade complementary transcripts.Howe

read more